Text Size

Endoscopic Ultrasound (EUS) Features of Chronic Pancreatitis

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Indiana University
ClinicalTrials.gov Identifier:
NCT01442454
First received: September 26, 2011
Last updated: September 11, 2012
Last verified: September 2012
History of Changes
  Purpose

The purpose of this study is to correlate Endoscopic Ultrasound (EUS) criteria for chronic pancreatitis with surgical pathology.


Condition Intervention
Chronic Pancreatitis
 Other: chronic pancreatitis

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Endoscopic Ultrasound (EUS) Features of Chronic Pancreatitis: A Prospective Correlation With Intraoperative Findings and Surgical Pathology

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Indiana University:

Estimated Enrollment: 100
Study Start Date: October 2010
Estimated Study Completion Date: December 2016
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Chronic Pancreatitis Other: chronic pancreatitis
No intervention, subjects followed through surgery

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Patients undergoing EUS

Criteria

Patients who are eligible are individuals who have:

  • normal pancreas
  • suspected chronic pancreatitis
  • established chronic pancreatitis (by ERCP, MRI, previous EUS, CT)
  • pancreatic cancer

Patients who are not eligible are individuals who have:

• an uncorrectable coagulopathy (platelet <50,000, INR>1.5), or bleeding disorder, or are unable to discontinue anticoagulation 5-7 days prior to EUS (aspirin and bridging therapy with lovenox are allowed, clopidogrel is not allowed)

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01442454

Locations
United States, Indiana
Indiana University Hospital
Indianapolis, Indiana, United States, 46202
Sponsors and Collaborators
Indiana University
  More Information

No publications provided

Responsible Party: Indiana University
ClinicalTrials.gov Identifier: NCT01442454     History of Changes
Other Study ID Numbers: 1008-15
Study First Received: September 26, 2011
Last Updated: September 11, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Indiana University:
chronic pancreatitis

Additional relevant MeSH terms:
Pancreatitis
Pancreatitis, Chronic
Pancreatic Diseases
Digestive System Diseases

ClinicalTrials.gov processed this record on June 17, 2013